Evolving strategies for surgical management of patients with severe left ventricular dysfunction

Heart Lung and Circulation

Volumn 12, Issue 1, 2003, Pages 31-38

  McCarthy, Patrick M ^a   Quader, Mohammed A ^a   Hoercher, Katherine J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Heart failure; Left ventricular reconstruction; Surgery

Indexed keywords

CARDIOVASCULAR SURGERY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS SURGERY; DISEASE SEVERITY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HEART TRANSPLANTATION; HEART VALVE SURGERY; HEART VENTRICLE REMODELING; HUMAN; PRIORITY JOURNAL; REVIEW; SURGEON;

EID: 0042634310     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1444-2892.2003.00188.x     Document Type: Review

References (67)

1. Loop FD. Coronary artery surgery: the end of the beginning. Eur. J. Cardiothorac. Surg, 1998; 14: 554-71.
2. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 83: 596-602.
3. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J. Thorac. Cardiovasc. Surg. 1998; 115: 381-6; discussion 387-8.
4. Bishay ES, McCarthy PM, Cosgrove DM et al. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur. J. Cardiothorac. Surg. 2000; 17: 213-21.
5. Emond M, Mock MB, Davis KB et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994; 90: 2645-57.
6. Kumpati GS, McCarthy PM, Hoercher KJ. Surgical treatments for heart failure. Cardiol. Clin. 2001; 19, 669-81.
7. Jain D, Zaret BL. Nuclear imaging techniques for the assessment of myocardial viability. Cardiol. Clin. 1995; 13: 43-57.
8. Marwick TH. The viable myocardium: epidemiology, detection, and clinical implications. Lancet 1998; 351: 815-9.
9. Marwick TH. Use of standard imaging techniques for prediction of postrevascularization functional recovery in patients with heart failure. J. Card. Fail. 1999; 5: 334-46.
10. Bonow RO, Carabello B, de Leon AC et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J. Heart Valve Dis. 1998; 7: 672-707.
11. Lee SJ, Bay KS. Mortality risk factors associated with mitral valve replacement: a survival analysis of 10 year follow-up data. Can. J. Cardiol. 1991; 7: 11-18.
12. Phillips HR, Levine FH, Carter JE et al. Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction. Am. J. Cardiol. 1981; 48: 647-54.
13. Tribouilloy CM, Enriquez-Sarano, M, Schaff HV et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999; 99: 400-5.
14. David TE, Uden DE, Strauss HD. The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation. Circulation 1983; 68: II76-82.
15. Bonow RO, Nikas D, Elefteriades JA. Valve replacement for regurgitant lesions of the aortic or mitral valve in advanced left ventricular dysfunction. Cardiol. Clin. 1995; 13: 85.
16. McCarthy PM. Aortic valve surgery in patients with left ventricular dysfunction. Semin. Thorac. Cardiovasc. Surg. 2002; 14: 137-43.
17. Pereira JJ, Lauer MS, Bashir M et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J. Am. Coll. Cardiol. 2002; 39: 1356-63.
18. Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 1978; 58: 255-64.
19. Kurrelmeyer K, Kalra D, Bozkurt B et al. Cardiac remodeling as a consequence and cause of progressive heart failure. Clin. Cardiol. 1998; 21: I14-9.
20. Dor V, Sabatier M, Di Donato M, Montiglio F, Toso A, Maioli M. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J. Thorac. Cardiovasc. Surg. 1998; 116: 50-59.
21. Buckberg GD. Commonality of ischemic and dilated cardiomyopathy: laplace and ventricular restoration. J. Card. Surg. 1999; 14: 53-9.
22. Mann DL. Inflammatory mediators in heart failure: homogeneity through heterogeneity. Lancet 1999; 353: 1812-13.
23. Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation 1999; 100: 999-1008.
24. Kapadia S, Dibbs Z, Kurrelmeyer K et al. The role of cytokines in the failing human heart. Cardiol. Clin. 1998; 16: 645-56, viii.
25. Dor V, Saab M, Coste P, Kornaszewska M, Montiglio F. Left ventricular aneurysm: a new surgical approach. Thorac. Cardiovasc. Surg. 1989; 37: 11-19.
26. Cooley DA. Ventricular endoaneurysmorrhaphy: a simplified repair for extensive postinfarction aneurysm. J. Card. Surg. 1989; 4: 200-5.
27. Jatene AD. Left ventricular aneurysmectomy. Resection or reconstruction. J. Thorac. Cardiovasc. Surg. 1985; 89: 321-31.
28. Di Donato M, Sabatier M, Toso A et al. Regional myocardial performance of non-ischaemic zones remote from anterior wall left ventricular aneurysm. Effects of aneurysmectomy. Eur. Heart J. 1995; 16: 1285-92.
29. Batista RJ, Santos JL, Takeshita N, Bocchino L, Lima PN, Cunha MA. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J. Card. Surg. 1996; 11: 96-7; discussion 98.
30. McCarthy PM, Starling RC, Wong J et al. Early results with partial left ventriculectomy. J. Thorac. Cardiovasc. Surg. 1997; 114: 755-63; discussion 763-5.
31. McCarthy PM, Fukamachi K, Takagaki M. Left ventricular shape change reduced left ventricular wall stress in patients with dilated cardiomyopathy. Circulation 2000; 102 (Suppl. II): 683.
32. Starling RC, McCarthy PM. Partial left ventriculectomy: sunrise or sunset? Eur. J. Heart Fail. 1999; 1: 313-17.
33. Starling RC, McCarthy PM, Buda T et al. Results of partial left ventriculectomy for dilated cardiomyopathy: hemodynamic, clinical and echocardiographic observations. J. Am. Coll. Cardiol. 2000; 36: 2098-103.
34. Stolf NA, Moreira LF, Bocchi EA et al. Determinants of midterm outcome of partial left ventriculectomy in dilated cardiomyopathy. Ann. Thorac. Surg. 1998; 66: 1585-91.
35. Hoercher KJ, Vacha CL, McCarthy PM. Left ventricular splints and wraps for end-stage heart failure: a new approach in the new millennium. J. Cardiovasc. Nurs. 2002; 16: 82-6.
36. Takagaki M, McCarthy PM, Dessoffy R et al. Device based left ventricular shape change: validation of conductance technology in shape changed hearts. Asaio J. 2002; 48: 268-71.
37. McCarthy PM, Takagaki M, Ochiai Y et al. Device-based change in left ventricular shape: a new concept for the treatment of dilated cardiomyopathy. J. Thorac. Cardiovasc. Surg. 2001; 122: 482-90.
38. Power J, Raman J, Byrne M. Passive ventricular constraint is a trigger for a significant degree of reverse remodeling in an experimental model of degenerative heart failure and dilated cardiomyopathy. Circulation 2000; 102 (Suppl. II): II-502.
39. Sabbah HN, Gupta RC, Sharov VG. Reverse remodeling and enhanced adrenergic reserve from a passive external ventricular support in experimental dilated heart failure. Circulation 2000; 102 (Suppl. II): II-683.
40. Raman JS, Power JM, Buxton BF, Alferness C, Hare D. Ventricular containment as an adjunctive procedure in ischemic cardiomyopathy: early results. Ann. Thorac. Surg. 2000; 70: 1124-6.
41. Raman JS, Hata M, Storer M et al. The mid-term results of ventricular containment (ACORN WRAP) for end-stage ischemic cardiomyopathy. Ann. Thorac. Cardiovasc. Surg. 2001; 7: 278-81.
42. Blanc JJ, Etienne Y, Gilard M et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 1997; 96: 3273-7.
43. Cazeau S, Ritter P, Lazarus A et al. [First experience in treatment of terminal cardiac insufficiency using multisite stimulation.] Bull. Acad. Natl Med. 1996; 180: 2065-75; discussion 2075-8.
44. Saxon LA, Boehmer JP, Hummel J et al. Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. Am. J. Cardiol. 1999; 83: 120D-123D.
45. Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med. 2001; 344: 873-80.
46. Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med. 2002; 346: 1845-53.
47. Scorsin M, Hagege AA, Marotte F et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation 1997; 96: II-188-93.
48. Menasche P. Cell transplantation for the treatment of heart failure. Semin. Thorac. Cardiovasc. Surg. 2002; 14: 157-66.
49. Menasche P, Hagege AA, Scorsin M et al. Myoblast transplantation for heart failure. Lancet 2001; 357: 279-80.
50. Sakai T, Ling Y, Payne TR, Huard J. The use of ex vivo gene transfer based on muscle-derived stem cells for cardiovascular medicine. Trends Cardiovasc. Med. 2002; 12: 115-20.
51. Min JY, Yang Y, Converso KL et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 2002; 92: 288-96.
52. Tomita S, Li RK, Weisel RD et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100: II247-56.
53. Akhter SA, Skaer CA, Kypson AP et al. Restoration of betaadrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc. Natl Acad. Sci. USA 1997; 94: 12100-5.
54. Mack CA, Patel SR, Schwarz EA et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg. 1998; 115: 168-76; discussion 176-7.
55. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 355: 213-22.
56. Askari AT, Penn MS. Targeted gene therapy for the treatment of cardiac dysfunction. Semin. Thorac. Cardiovasc. Surg. 2002; 14: 167-77.
57. Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N. Engl. J. Med. 2001; 345: 1435-43.
58. Wieselthaler GM, Schima H, Lassnigg AM et al. Lessons learned from the first clinical implants of the DeBakey ventricular assist device axial pump: a single center report. Ann. Thorac. Surg. 2001; 71: S139-43; discussion S144-6.
59. Frazier OH, Myers TJ, Gregoric ID et al. Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation 2002; 105: 2855-60.
60. Ochiai Y, Golding LA, Massiello AL et al. In vivo hemodynamic performance of the Cleveland Clinic CorAide blood pump in calves. Ann. Thorac. Surg. 2001; 72: 747-52.
61. Saito S, Westaby S, Piggott D et al. Reliable long-term non-pulsatile circulatory support without anticoagulation. Eur. J. Cardiothorac. Surg. 2001; 19: 678-83.
62. Yacoub MH, Tansley P, Birks EJ, Bowles C, Banner WR, Khaghan A. A novel combination therapy to reverse end-stage heart failure. Transplant Proc. 2001; 33: 2762-4.
63. Milano CA, White WD, Smith LR et al. Coronary artery bypass in patients with severely depressed ventricular function. Ann. Thorac. Surg. 1993; 56: 487-93.
64. Shapira I, Isakov A, Yakirevich V, Topilsky M. Long-term results of coronary artery bypass surgery in patients with severely depressed left ventricular function. Chest 1995; 108: 1546-50.
65. Elefteriades JA, Morales DL, Gradel C, Tollis G Jr, Levi E, Zaret BL. Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions < or = 30%. Am. J. Cardiol. 1997; 79: 1573-8.
66. De Carlo M, Milano A, Borzoni G et al. Predicting outcome after myocardial revascularization in patients with left ventricular dysfunction. Cardiovasc. Surg. 1998; 6: 58-66.
67. Luciani GB, Montalbano G, Casali G, Mazzucco A. Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 2000; 120: 478-89.